New, Enhanced Capabilities Enable Accelerated Drug Discovery, Enhanced Biomedical Literature Review, and Improved Hallucination Detection in LLMs

John Snow Labs, the AI for healthcare company, announced the acquisition of WiseCube, a pioneer in biomedical knowledge graphs and AI-powered literature analysis. The acquisition strengthens the company’s mission to deliver responsible, accurate, and explainable healthcare AI solutions enhanced by WiseCube’s billion-scale knowledge platform.

WiseCube unifies and analyzes disjointed biomedical datasets to provide fast, literature-backed answers to complex medical questions. Its integration of cutting-edge biomedical ontologies and documents ensures access to the most current and comprehensive medical knowledge. This capability has proven indispensable, uncovering new use cases and solutions John Snow Labs can support, such as drug discovery and precision medicine within the Medical Chatbot Platform.

The WiseCube acquisition will enable John Snow Labs to:

  • Enhance Biomedical Literature Review: Unique algorithms enable holistic analysis of unstructured data and medical ontologies to generate new scientific hypotheses.
  • Accelerate Drug Discovery: Surfacing hidden relationships among drugs, genes, and diseases, WiseCube shortens the path from discovery to clinical trials.
  • Improve Hallucination Detection for Medical LLMs: WiseCube’s Pythia service includes a hallucination detection tool that can monitor AI-generated responses alignment with verified medical knowledge, enhancing compliance and safety of medical AI applications.

“With John Snow Labs’ leadership in healthcare AI, our combined teams can now bring safe and effective AI solutions to the market at scale,” said Vishnu Vettrivel, CEO, WiseCube. “We look forward to improving research productivity, clinical decision-making, and patient outcomes together.”

“The integration of WiseCube’s knowledge graph technology into our healthcare AI solutions enables a new level of accuracy and reliability for our customers,” said David Talby, CEO, John Snow Labs. “We’re excited to accelerate the ability to deliver real-world, production-ready solutions that clinicians and researchers can trust.”

Health Technology Insights: MedTrainer Launches AI Compliance Coach for Healthcare Teams

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – GlobeNewswire